Jaguar Health (JAGX) Gains from Investment Securities (2015 - 2018)
Jaguar Health (JAGX) posted quarterly Gains from Investment Securities of $23000.0 for Q1 2018, down 94.93% year-over-year from $453419.0 in Q1 2017, and down 96.69% quarter-over-quarter from $695341.0 in Q4 2017.
Jaguar Health (JAGX) Gains from Investment Securities (2015 - 2018) Analysis & Trends
Jaguar Health (JAGX) has reported Gains from Investment Securities for 4 consecutive years, with $23000.0 the latest figure, recorded in Q1 2018.
- In Q1 2018, Gains from Investment Securities fell 94.93% year-over-year to $23000.0; the TTM figure through Mar 2018 stood at -$201321.0 (down 132.13% YoY), while the FY2018 annual figure was $23894.0, down 96.56% from the prior year.
- Gains from Investment Securities eased to $23000.0 in Q1 2018 per JAGX's latest filing, from $695341.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $695341.0 in Q4 2017 and bottomed at -$700740.0 in Q2 2017.
- Historically, Gains from Investment Securities has averaged $129854.6 across 4 years, with a median of $108150.5 in 2015.
- Annual changes were most pronounced in 2017 — Gains from Investment Securities jumped 1509.59% — and 2018, when it plunged 94.93%.
- Jaguar Health's Gains from Investment Securities stood at $173101.0 in 2015, then plunged by 75.04% to $43200.0 in 2016, then jumped by 1509.59% to $695341.0 in 2017, then plunged by 96.69% to $23000.0 in 2018.
- Business Quant data shows JAGX's Gains from Investment Securities at $23000.0 in Q1 2018, $695341.0 in Q4 2017, and $23000.0 in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Jaguar Health | 447,549.24 | -9.62 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 23,000.00 |
| Mar 31, 2018 | 23,000.00 |
| Dec 31, 2017 | 695,341.00 |
| Dec 31, 2017 | 695,341.00 |
| Sep 30, 2017 | 23,000.00 |
| Sep 30, 2017 | 23,000.00 |
| Jun 30, 2017 | -700,740.00 |
| Jun 30, 2017 | -700,740.00 |
| Mar 31, 2017 | 453,419.00 |
| Mar 31, 2017 | 453,419.00 |
| Dec 31, 2016 | 43,200.00 |
| Dec 31, 2016 | 43,200.00 |
| Jun 30, 2015 | 173,101.00 |
| Jun 30, 2015 | 173,101.00 |
| Mar 31, 2015 | 328,516.00 |
| Mar 31, 2015 | 328,516.00 |